Skip to main navigation Skip to search Skip to main content

DESIGNATE: A T cell phenotype signature driven dose finding study with siplizumab in type 1 diabetes mellitus

    Project: Research

    Project Details

    StatusActive
    Effective start/end date02/1/23 → …